|
CDKN2B-AS1
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
ANRIL polymorphisms (rs1333049 and rs3217992) in relation to plasma CRP levels among in-patients with CHD.
|
31770616 |
2020 |
|
CDKN2B-AS1
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
CDKN2B-AS1 rs10738606 was significantly associated with CHD under codominant (p = .03), dominant (p = .019), recessive (p = .010), additive (p = .003), and allele (p = .003) models.
|
31496134 |
2019 |
|
CDKN2B-AS1
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Association of CDKN2BAS gene polymorphism with periodontitis and Coronary Artery Disease from South Indian population.
|
31173806 |
2019 |
|
CDKN2B-AS1
|
0.200 |
Biomarker
|
disease |
BEFREE |
The association between the chromosome 9p21 CDKN2B-AS1 gene variants and the lipid metabolism: A pre-diagnostic biomarker for coronary artery disease.
|
30587704 |
2019 |
|
CDKN2B-AS1
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Effects of ANRIL polymorphisms on the likelihood of coronary artery disease: A meta-analysis.
|
30387168 |
2019 |
|
CDKN2B-AS1
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Association of CDKN2B-AS1 Polymorphisms with Premature Triple-vessel Coronary Disease and Their Sex Specificity in the Chinese Population.
|
30558699 |
2018 |
|
CDKN2B-AS1
|
0.200 |
GeneticVariation
|
disease |
GWASCAT |
Strong impact of natural-selection-free heterogeneity in genetics of age-related phenotypes.
|
29615537 |
2018 |
|
CDKN2B-AS1
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
ANRIL polymorphism rs4977574 is associated with increased risk of coronary artery disease in Asian populations: A meta-analysis of 12,005 subjects.
|
30278588 |
2018 |
|
CDKN2B-AS1
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Association of ANRIL Expression with Coronary Artery Disease in Type 2 Diabetic Patients.
|
29308617 |
2018 |
|
CDKN2B-AS1
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Genome-wide association analysis of all-cause HF identified several suggestive loci ( P<1×10<sup>-6</sup>), the majority linked to upstream HF risk factors, ie, coronary artery disease ( CDKN2B-AS1 and MAP3K7CL) and atrial fibrillation ( PITX2).
|
30586722 |
2018 |
|
CDKN2B-AS1
|
0.200 |
Biomarker
|
disease |
BEFREE |
The interplay of LncRNA ANRIL and miR-181b on the inflammation-relevant coronary artery disease through mediating NF-κB signalling pathway.
|
30079603 |
2018 |
|
CDKN2B-AS1
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Recent genome-wide association studies (GWAS) in European populations have indicated that the rs12526453 polymorphism located in phosphatase and actin regulator 1 gene (PHACTR1), mapping to chromosome 6p24 and rs7865618 polymorphism in the cyclin-dependent kinase inhibitor B antisense RNA 1 gene (CDKN2B-AS1) on 9p21.3 are associated with coronary heart disease (CHD).
|
28287809 |
2017 |
|
CDKN2B-AS1
|
0.200 |
Biomarker
|
disease |
BEFREE |
CDKN2B-AS may indirectly regulate coronary artery disease-associated genes via targeting miR-92a.
|
28760552 |
2017 |
|
CDKN2B-AS1
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Intronic Polymorphisms in the CDKN2B-AS1 Gene Are Strongly Associated with the Risk of Myocardial Infarction and Coronary Artery Disease in the Saudi Population.
|
26999117 |
2016 |
|
CDKN2B-AS1
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
The prominent lncRNA antisense noncoding RNA in the INK4 locus (ANRIL), which has been unequivocally associated with coronary artery disease through genome-wide association studies (GWAS), serves as an example to demonstrate the features of each individual database.
|
27049585 |
2016 |
|
CDKN2B-AS1
|
0.200 |
PosttranslationalModification
|
disease |
BEFREE |
Our findings suggest developmental epigenetic regulation of ANRIL promoter methylation as a factor in later CHD risk in children.
|
27594927 |
2016 |
|
CDKN2B-AS1
|
0.200 |
GeneticVariation
|
disease |
GWASCAT |
Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.
|
27790247 |
2016 |
|
CDKN2B-AS1
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Interestingly, the haplotype AA (rs10757274 and rs1333042) of CDKN2BAS was associated with decreased the risk of CHD in men (OR = 0.72, 95% CI: 0.55 - 0.95, P = 0.022).
|
27741513 |
2016 |
|
CDKN2B-AS1
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
ANRIL has long been considered as the strongest candidate gene at the 9p21 locus, robustly associated with stroke and coronary artery disease.
|
24385277 |
2014 |
|
CDKN2B-AS1
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Association of CDKN2BAS polymorphism rs4977574 with coronary heart disease: a case-control study and a meta-analysis.
|
25268619 |
2014 |
|
CDKN2B-AS1
|
0.200 |
GeneticVariation
|
disease |
GWASCAT |
Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants.
|
24262325 |
2014 |
|
CDKN2B-AS1
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Our thorough genomic characterization of 9p21.3 suggests common variants likely account for observed disease associations and provides further support for the hypothesis that complex regulatory variation affecting ANRIL and CDKN2B gene expression may contribute to increased risk for clinically apparent and subclinical coronary artery disease and aortic disease.
|
23315372 |
2013 |
|
CDKN2B-AS1
|
0.200 |
GeneticVariation
|
disease |
GWASDB |
A genome-wide association study of a coronary artery disease risk variant.
|
23364394 |
2013 |
|
CDKN2B-AS1
|
0.200 |
GeneticVariation
|
disease |
GWASCAT |
A genome-wide association study of a coronary artery disease risk variant.
|
23364394 |
2013 |
|
CDKN2B-AS1
|
0.200 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study in Han Chinese identifies four new susceptibility loci for coronary artery disease.
|
22751097 |
2012 |